{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:20Z","timestamp":1792521440881,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["301202"],"award-info":[{"award-number":["301202"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013690","name":"Minist\u00e8re de l&apos;\u00c9conomie, de la Science et de l&apos;Innovation - Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.03.058","type":"journal-article","created":{"date-parts":[[2017,4,9]],"date-time":"2017-04-09T00:46:12Z","timestamp":1491698772000},"page":"2592-2599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro"],"prefix":"10.1016","volume":"35","author":[{"given":"Hilary E.","family":"Hendin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Pillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda N.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Charland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.058_b0005","unstructured":"WHO. Influenza Seasonal. Media Center, Geneva. Fact sheet no 211."},{"key":"10.1016\/j.vaccine.2017.03.058_b0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1637\/10204-041412-ResNote.1","article-title":"Development of an influenza virologic risk assessment tool","volume":"56","author":"Trock","year":"2012","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2017.03.058_b0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines","volume":"361","author":"Monto","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.058_b0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/589885","article-title":"Prevention of symptomatic seasonal influenza in 2005\u20132006 by inactivated and live attenuated vaccines","volume":"198","author":"Ohmit","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.058_b0025","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/507709","article-title":"Cross-protectiveness and immunogenicity of influenza A\/Duck\/Singapore\/3\/97(H5) vaccines against infection with A\/Vietnam\/1203\/04(H5N1) virus in ferrets","volume":"194","author":"Lipatov","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.058_b0030","doi-asserted-by":"crossref","first-page":"e15559","DOI":"10.1371\/journal.pone.0015559","article-title":"Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza","volume":"5","author":"Landry","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.058_b0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.vaccine.2012.10.111","article-title":"Global production capacity of seasonal influenza vaccine in 2011","volume":"31","author":"Partridge","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.058_b0040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1473-3099(08)70232-9","article-title":"Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans","volume":"8","author":"Jennings","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.058_b0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4149\/av_2010_01_7","article-title":"Trends in development of the influenza vaccine with broader cross-protection","volume":"54","author":"Stropkovska","year":"2010","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2011.09.037","article-title":"Novel vaccines against influenza viruses","volume":"162","author":"Kang","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.03.058_b0055","first-page":"1","article-title":"Progress in developing virus-like particle influenza vaccines","author":"Quan","year":"2016","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.03.058_b0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/erv.12.147","article-title":"Virus-like particles produced in plants as potential vaccines","volume":"12","author":"Scotti","year":"2013","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2017.03.058_b0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2017.03.058_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2014.08.003","article-title":"Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens","author":"Landry","year":"2014","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"10.1016\/j.vaccine.2017.03.058_b0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2016.03.008","article-title":"A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults","volume":"168","author":"Pillet","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0080","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2015.09.065","article-title":"Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets","volume":"33","author":"Pillet","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.058_b0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2017.03.058_b0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","article-title":"Sialic acids in human health and disease","volume":"14","author":"Varki","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2017.03.058_b0095","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1074\/jbc.R110.191429","article-title":"Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function","volume":"286","author":"Zhuo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.03.058_b0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.micinf.2010.10.004","article-title":"Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus","volume":"13","author":"Tate","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2017.03.058_b0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9440(10)63132-X","article-title":"Differential distribution of the JC virus receptor-type sialic acid in normal human tissues","volume":"164","author":"Eash","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0110","article-title":"Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses","volume":"5","author":"Medina","year":"2013"},{"key":"10.1016\/j.vaccine.2017.03.058_b0115","doi-asserted-by":"crossref","first-page":"18137","DOI":"10.1073\/pnas.0909696106","article-title":"Glycans on influenza hemagglutinin affect receptor binding and immune response","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.03.058_b0120","doi-asserted-by":"crossref","first-page":"e38794","DOI":"10.1371\/journal.pone.0038794","article-title":"Two glycosylation sites in H5N1 influenza virus hemagglutinin that affect binding preference by computer-based analysis","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.058_b0125","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/v6031294","article-title":"Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection","volume":"6","author":"Tate","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.03.058_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1440-1711.2003.01152.x","article-title":"Isolation of antigen-specific B cells","volume":"81","author":"Kodituwakku","year":"2003","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0135","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4049\/jimmunol.170.2.686","article-title":"Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses","volume":"170","author":"Tangye","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0140","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","article-title":"Distinct profiles of human B cell effector cytokines: a role in immune regulation?","volume":"172","author":"Duddy","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0145","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.4049\/jimmunol.174.11.6781","article-title":"Regulation of IFN-gamma production by B effector 1 cells: essential roles for T-bet and the IFN-gamma receptor","volume":"174","author":"Harris","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0150","doi-asserted-by":"crossref","first-page":"36298","DOI":"10.1038\/srep36298","article-title":"Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation","volume":"6","author":"Villar","year":"2016","journal-title":"Scient Rep"},{"key":"10.1016\/j.vaccine.2017.03.058_b0155","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JVI.01705-10","article-title":"N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN","volume":"85","author":"Londrigan","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0160","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1038\/ncomms3763","article-title":"A Ca(2+)-dependent signalling circuit regulates influenza A virus internalization and infection","volume":"4","author":"Fujioka","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2017.03.058_b0165","first-page":"23","article-title":"Innate immune sensing and response to influenza","volume":"386","author":"Pulendran","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0170","doi-asserted-by":"crossref","first-page":"e1005303","DOI":"10.1371\/journal.ppat.1005303","article-title":"Human metapneumovirus is capable of entering cells by fusion with endosomal membranes","volume":"11","author":"Cox","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.03.058_b0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-59745-178-9_3","article-title":"In vitro assays to measure SNARE-mediated vesicle fusion","volume":"440","author":"Kreye","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2017.03.058_b0180","doi-asserted-by":"crossref","first-page":"e8159","DOI":"10.1371\/journal.pone.0008159","article-title":"Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice","volume":"4","author":"Abadie","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.058_b0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0105-2896.2006.00382.x","article-title":"Signals required for programming effector and memory development by CD8+ T cells","volume":"211","author":"Mescher","year":"2006","journal-title":"Immunol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T02:37:52Z","timestamp":1655692672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":37,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17303754"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}